HomeCompareTBLT vs MRK

TBLT vs MRK: Dividend Comparison 2026

TBLT yields 1000000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TBLT wins by $188409716392645591040.00M in total portfolio value
10 years
TBLT
TBLT
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$188409716392645591040.00M
Annual income
$156,820,396,180,463,870,000,000,000.00
Full TBLT calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TBLT vs MRK

📍 TBLT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTBLTMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TBLT + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TBLT pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBLT
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$133,297,336,753,394,290,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TBLT beats the other by $133,297,336,753,394,290,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBLT + MRK for your $10,000?

TBLT: 50%MRK: 50%
100% MRK50/50100% TBLT
Portfolio after 10yr
$94204858196322795520.00M
Annual income
$78,410,198,090,231,930,000,000,000.00/yr
Blended yield
83.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TBLT
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-7.2
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBLT buys
0
MRK buys
0
No recent congressional trades found for TBLT or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTBLTMRK
Forward yield1000000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$188409716392645591040.00M$56.8K
Annual income after 10y$156,820,396,180,463,870,000,000,000.00$9,798.13
Total dividends collected$186170298512243982336.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: TBLT vs MRK ($10,000, DRIP)

YearTBLT PortfolioTBLT Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,206$366.19+$50.00MTBLT
2$116,900,941,356$116,847,429,906.54$12,650$502.35+$116900.93MTBLT
3$127,757,345,946,658$127,632,261,939,407.38$14,407$694.19+$127757345.93MTBLT
4$65,316,731,768,579,704$65,180,031,408,416,776.00$16,585$967.82+$65316731768.56MTBLT
5$15,641,708,257,005,480,000$15,571,819,354,013,100,000.00$19,342$1,363.89+$15641708257005.46MTBLT
6$1,759,286,910,766,321,500,000$1,742,550,282,931,325,600,000.00$22,913$1,947.19+$1759286910766321.50MTBLT
7$93,467,370,779,778,750,000,000$91,584,933,785,258,800,000,000.00$27,662$2,823.89+$93467370779778752.00MTBLT
8$2,373,712,470,630,401,000,000,000$2,273,702,383,896,037,800,000,000.00$34,159$4,173.35+$2373712470630401024.00MTBLT
9$29,522,729,170,263,285,000,000,000$26,982,856,826,688,750,000,000,000.00$43,337$6,308.80+$29522729170263285760.00MTBLT
10$188,409,716,392,645,600,000,000,000$156,820,396,180,463,870,000,000,000.00$56,776$9,798.13+$188409716392645591040.00MTBLT

TBLT vs MRK: Complete Analysis 2026

TBLTStock

ToughBuilt Industries, Inc. designs, develops, manufactures, and distributes home improvement and construction products for the building industry in the United States and internationally. It offers tool pouches, tool rigs, tool belts and accessories, tools bags, totes, various storage solutions, and office organizers/bags for laptop/tablet/cellphones, etc.; and kneepads. The company also provides sawhorses, miter saws, table saws, roller stands, and workbenches; sawhorse/jobsite tables; and digital measure and levels. It offers its products under the TOUGHBUILT brand through various home improvement big box stores, professional outlets, and direct marketing to construction companies and trade/wholesale outlets. The company was formerly known as Phalanx, Inc. and changed its name to ToughBuilt Industries, Inc. in December 2015. ToughBuilt Industries, Inc. was incorporated in 2012 and is based in Lake Forest, California.

Full TBLT Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TBLT vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBLT vs SCHDTBLT vs JEPITBLT vs OTBLT vs KOTBLT vs MAINTBLT vs JNJTBLT vs ABBVTBLT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.